# Ipremom Pregnancy Healthcare Diagnostics SL

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ipremom-pregnancy-healthcare-diagnostics-sl

- Industry: Biotechnology
- Headquarters: Valencia, Spain
- Total disclosed funding: $17M
- Latest round: Seed (Sep 2, 2026)
- Investors on record: 3

## About

Based in Valencia, Spain and founded in 2019, iPremom Pregnancy Healthcare Diagnostics, S.L. provides molecular diagnostics solutions for maternal healthcare. The company was founded by Carlos Simón and Tamara Garrido. In September 2026, Ipremom Pregnancy Healthcare Diagnostics SL raised EUR 15 million in seed funding co-led by investors Amadeus Capital Partners, and Asabys Partners, with participation from other investor APEX Ventures.
The company develops molecular diagnostic platforms, prenatal screening tools, cell-free RNA analysis technologies, AI-based pregnancy risk prediction models, preeclampsia assessment solutions, clinical laboratory testing services, and maternal-fetal health diagnostics. Its flagship MaiRa platform evaluates pregnancy-complication risks from early gestation blood samples.
The company generates revenue through molecular diagnostic testing services, prenatal screening products, clinical laboratory services, pregnancy risk assessment solutions, healthcare provider partnerships, commercialization of the MaiRa platform, and future regulatory-approved diagnostic applications for maternal and fetal healthcare.
The company plans to use the funding to validate and commercialize its MaiRa platform and pursue regulatory approvals.

## Funding rounds

- Seed, Sep 2, 2026, $17M — Amadeus Capital Partners, Apex Ventures, Asabys Partners

## Investors

- Amadeus Capital Partners (https://capitalatlas.ai/funds/amadeus-capital-partners) — Seed
- Apex Ventures (https://capitalatlas.ai/funds/apex-ventures) — Seed
- Asabys Partners (https://capitalatlas.ai/funds/asabys-partners) — Seed